Awakn Life Sciences Corp.
AWKNF · OTC
10/31/2024 | 7/31/2024 | 4/30/2024 | 1/31/2024 | |
|---|---|---|---|---|
| Market Cap | $4 | $4 | $7 | $5 |
| - Cash | $1 | $1 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $4 | $4 | $7 | $4 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | -66.6% | -46.8% | -5.2% | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | 100% | 100% | 77% | 78.1% |
| EBITDA | -$0 | -$1 | -$1 | -$1 |
| % Margin | -12,735.4% | -5,255% | -2,511.9% | -3,839.2% |
| Net Income | -$0 | -$0 | -$1 | -$1 |
| % Margin | -10,248.7% | -3,283.5% | -2,634.6% | -4,698.4% |
| EPS Diluted | -0.011 | -0.011 | -0.014 | -0.026 |
| % Growth | -4.7% | 23.7% | 46.9% | – |
| Operating Cash Flow | -$1 | $0 | -$1 | -$0 |
| Capital Expenditures | $0 | $0 | $0 | $0 |
| Free Cash Flow | -$1 | $0 | -$1 | -$0 |